Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Analysis of the Safety Profiles of Anticoagulants Using the EMA Pharmacovigilance Database

Ismail Elalamy, MD PhD

Blood (2019) 134 (Supplement_1): 4979.

https://doi.org/10.1182/blood-2019-123031

Published: 2019

Journal Articles

Pharmacovigilance of a Rituximab Biosimilar (Novex) in Argentina

Gustavo Milone, MD, Francisco Fernandez, Maria Ines Penna, Roberto Gomez

Blood (2016) 128 (22): 3568.

https://doi.org/10.1182/blood.V128.22.3568.3568

Published: 2016

Journal Articles

The Importance of Pharmacovigilance during Ibrutinib Therapy for Chronic Lymphocytic Leukemia (CLL) in Routine Clinical Practice

Heidi D. Finnes, PharmD, Kari G. Chaffee, MS, Timothy G. Call, MD, Wei Ding, MD PhD, Deborah A. Bowen, APRN, CNP, Michael Conte, PA-C, Kristen B. McCullough, PharmD, Julianna A. Merten, PharmD, Gabriel T. Bartoo, PharmD, Matthew D. Smith, PharmD, Susan M. Schwager, Susan L. Slager, PhD, Neil E. Kay, MD, Tait D. Shanafelt, MD, Sameer A. Parikh, MD

Blood (2015) 126 (23): 717.

https://doi.org/10.1182/blood.V126.23.717.717

Published: 2015

Journal Articles

Lower Leukocytosis with Biosimilar Compared with Originator G-CSF during Autologous Stem Cell Mobilization after Chemotherapy in Lymphoma and Multiple Myeloma Patients. a Pharmacovigilance Study of “Rete Ematologica Lombarda” (FARMA-REL)

Anna Maria Pelizzari, MD, Paola Tozzi, PharmD, Francesca Bocchio, Maurizio Bonfichi, Silvia Artuso, Nicola Fracchiolla, MD, Valentino Conti, Pierino Ferremi, Camillo Almici, MD, Daria Bettoni, Vincenza Orlando, PharmD, Giuseppe Rossi, MD, Giuliana Muti

Blood (2014) 124 (21): 5836.

https://doi.org/10.1182/blood.V124.21.5836.5836

Published: 2014

Journal Articles

Translating Research Into Policy: A Review of Pharmacovigilance Efforts From the Southern Network On Adverse Reactions (SONAR) Group

Charles Bennett, MD, PhD, MPP, Leann Norris, PharmD, Zaina Parvez Qureshi, PhD, MPH, April Miller, PharmD, Brandon Bookstaver, PharmD, BCPS (AQ-ID), AAHIVE, Donald Mattison, M.D., CAPT, USPHS

Blood (2011) 118 (21): 4756.

https://doi.org/10.1182/blood.V118.21.4756.4756

Published: 2011

Journal Articles

A Canadian Prospective, Observational, Open-Label, Pharmacovigilance Study to Assess the Safety of Humate-P ® Injection Volume Reduced (ivr) in Patients with Von Willebrand Disease.

Alan Tinmouth, MD, FRCPC, Victor S. Blanchette, Ramachandran Devaraj, Bruce Ritchie, David Barnes, Gigi van den Hoef

Blood (2009) 114 (22): 4190.

https://doi.org/10.1182/blood.V114.22.4190.4190

Published: 2009

Journal Articles

Aplidin Cardiac Safety Analysis.

Arturo Soto-Matos, MD, Sergio Szyldergemajn, MD, Javier Gomez, PhD, Sonia Extremera, BS, Bernardo Miguel-Lillo, PhD, Vicente Alfaro, PhD, Cinthya Coronado, MD, Pilar Lardelli, MD, Elena Roy, MD, Claudia S. Corrado, MD, Alejandro Yovine, MD, Carmen Kahatt, MD

Blood (2009) 114 (22): 4820.

https://doi.org/10.1182/blood.V114.22.4820.4820

Published: 2009

Journal Articles

Patient Safety in the Context of Disease Outcome and Effectiveness of Therapy.

Marlies E.H.M. Van Hoef, MD, PhD, MBA

Blood (2007) 110 (11): 4959.

https://doi.org/10.1182/blood.V110.11.4959.4959

Published: 2007

Journal Articles

Rapid Identification of Hematology-Associated Serious Adverse Drug Reactions (sADRS) with Small Datasets: Findings from the Research on Adverse Drug Events and Reports (RADAR) Project.

Nina Undevia, MD MPH, Cara C. Tigue, BA, Dennis P. West, PhD, June M. McKoy, MD MPH JD, Beatrice J. Edwards, MD, David A. Dorr, MD MS, Dennis W. Raisch, RPh PhD, Charles L. Bennett, MD, PhD, MPP

Blood (2007) 110 (11): 3339.

https://doi.org/10.1182/blood.V110.11.3339.3339

Published: 2007

Journal Articles

Helixate®Nexgen in the Treatment of Patients with Hemophilia A: A Long-Term Pharmacovigilance Surveillance.

Sabine Haertel, Claudia Zacharias, Hans-Herrmann Brackmann, Zimmermann Roland, Lenk Harald

Blood (2005) 106 (11): 4091.

https://doi.org/10.1182/blood.V106.11.4091.4091

Published: 2005

Journal Articles

Long-Term Follow-Up of Recombinant Human Erythropoietin (epoetin)Induced Pure Red Cell Aplasia (PRCA): A Comparison of Data Collected through Active and Passive Pharmacovigilance Efforts.

Charles L. Bennett, MD, PhD, Kenneth R. Carson, MD, June M. McKoy, MD, JD, MPH, Steven M. Belknap, MD, Stephen A. Klinge, BA, Andrew M. Evens, MD, Dennis W. Raisch, PhD, Paul R. Yarnold, PhD, Benjamin Kim, MD, Elizabeth A. Lyons, BA, Timothy K. Kuzel, MD, Martin S. Tallman, MD

Blood (2004) 104 (11): 5319.

https://doi.org/10.1182/blood.V104.11.5319.5319

Published: 2004

Journal Articles

Twelve Month Post Licensure Safety and Efficacy Data of Advate rFVIII PFM.

Edward D. Gomperts, MB, BCh, MD, Bruce M. Ewenstein, MD, PhD, Mary Ellen O’Banion, RN, MSN

Blood (2004) 104 (11): 3090.

https://doi.org/10.1182/blood.V104.11.3090.3090

Published: 2004

Journal Articles

Post-Marketing Assessments of Serious Adverse Drug Reactions Reported by the Manufacturer to the FDA Differ Markedly with Those from an Independent Pharmacovigilance Program: Empirical Findings Based on Bisphosphonate-Associated Osteonecrosis Descriptions by the Research on Adverse Events and Reports Project and the Product Manufacturer.

Victoria Kut, MD, J. Mehta, MD, S. Singhal, MD, C. Bennett, MD, PhD

Blood (2004) 104 (11): 3151.

https://doi.org/10.1182/blood.V104.11.3151.3151

Published: 2004

NARROW

Analysis of the Safety Profiles of Anticoagulants Using the EMA Pharmacovigilance Database

Pharmacovigilance of a Rituximab Biosimilar (Novex) in Argentina

The Importance of Pharmacovigilance during Ibrutinib Therapy for Chronic Lymphocytic Leukemia (CLL) in Routine Clinical Practice

Lower Leukocytosis with Biosimilar Compared with Originator G-CSF during Autologous Stem Cell Mobilization after Chemotherapy in Lymphoma and Multiple Myeloma Patients. a Pharmacovigilance Study of “Rete Ematologica Lombarda” (FARMA-REL)

Translating Research Into Policy: A Review of Pharmacovigilance Efforts From the Southern Network On Adverse Reactions (SONAR) Group

A Canadian Prospective, Observational, Open-Label, Pharmacovigilance Study to Assess the Safety of Humate-P ® Injection Volume Reduced (ivr) in Patients with Von Willebrand Disease.

Aplidin Cardiac Safety Analysis.

Patient Safety in the Context of Disease Outcome and Effectiveness of Therapy.

Rapid Identification of Hematology-Associated Serious Adverse Drug Reactions (sADRS) with Small Datasets: Findings from the Research on Adverse Drug Events and Reports (RADAR) Project.

Helixate®Nexgen in the Treatment of Patients with Hemophilia A: A Long-Term Pharmacovigilance Surveillance.

Long-Term Follow-Up of Recombinant Human Erythropoietin (epoetin)Induced Pure Red Cell Aplasia (PRCA): A Comparison of Data Collected through Active and Passive Pharmacovigilance Efforts.

Twelve Month Post Licensure Safety and Efficacy Data of Advate rFVIII PFM.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only